Astera Labs, Inc. (NASDAQ:ALAB – Get Free Report) shares traded up 2.7% during mid-day trading on Wednesday . The company traded as high as $290.63 and last traded at $290.30. Approximately 1,872,102 shares were traded during mid-day trading, a decline of 65% from the average daily volume of 5,399,010 shares. The stock had previously closed at $282.65.
Analysts Set New Price Targets
A number of analysts have commented on the stock. JPMorgan Chase & Co. upped their target price on shares of Astera Labs from $205.00 to $280.00 and gave the company an “overweight” rating in a report on Wednesday, May 6th. Roth Capital reiterated a “buy” rating and set a $450.00 price target on shares of Astera Labs in a research note on Wednesday, August 5th. Needham & Company LLC boosted their price objective on shares of Astera Labs from $260.00 to $425.00 and gave the company a “buy” rating in a research report on Wednesday, August 5th. Weiss Ratings reissued a “hold (c)” rating on shares of Astera Labs in a research report on Tuesday, August 18th. Finally, Stifel Nicolaus upped their price objective on Astera Labs from $260.00 to $460.00 and gave the stock a “buy” rating in a research note on Wednesday, June 24th. One research analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and eight have given a Hold rating to the company’s stock. According to data from MarketBeat, Astera Labs currently has a consensus rating of “Moderate Buy” and a consensus price target of $333.00.
View Our Latest Report on Astera Labs
Astera Labs Trading Up 2.7%
Astera Labs (NASDAQ:ALAB – Get Free Report) last posted its quarterly earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share for the quarter, topping analysts’ consensus estimates of $0.69 by $0.11. The business had revenue of $392.40 million during the quarter, compared to analyst estimates of $360.85 million. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The company’s revenue was up 104.5% on a year-over-year basis. During the same period in the prior year, the business posted $0.44 earnings per share. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. Sell-side analysts anticipate that Astera Labs, Inc. will post 2.7 EPS for the current year.
Insider Activity at Astera Labs
In other Astera Labs news, COO Sanjay Gajendra sold 90,630 shares of the firm’s stock in a transaction dated Monday, August 17th. The stock was sold at an average price of $340.35, for a total transaction of $30,845,920.50. Following the sale, the chief operating officer directly owned 1,119,038 shares of the company’s stock, valued at $380,864,583.30. This trade represents a 7.49% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Stefan A. Dyckerhoff sold 8,994 shares of the business’s stock in a transaction dated Wednesday, July 1st. The shares were sold at an average price of $450.00, for a total value of $4,047,300.00. Following the completion of the transaction, the director owned 4,631 shares in the company, valued at $2,083,950. The trade was a 66.01% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 419,244 shares of company stock worth $163,135,169 in the last 90 days. Company insiders own 10.40% of the company’s stock.
Institutional Trading of Astera Labs
Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Greenleaf Trust raised its position in Astera Labs by 1.8% in the 2nd quarter. Greenleaf Trust now owns 2,000 shares of the company’s stock worth $966,000 after purchasing an additional 36 shares during the period. Glenmede Trust Co. NA boosted its position in shares of Astera Labs by 2.7% during the first quarter. Glenmede Trust Co. NA now owns 1,909 shares of the company’s stock valued at $209,000 after buying an additional 51 shares during the period. Keating Financial Advisory Services Inc. bought a new position in shares of Astera Labs during the second quarter valued at approximately $25,000. Lido Advisors LLC grew its stake in shares of Astera Labs by 0.5% during the fourth quarter. Lido Advisors LLC now owns 12,297 shares of the company’s stock valued at $2,046,000 after buying an additional 57 shares during the last quarter. Finally, Archer Investment Corp purchased a new stake in shares of Astera Labs in the second quarter worth approximately $30,000. Institutional investors own 60.47% of the company’s stock.
About Astera Labs
Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.
The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.
Featured Stories
- Five stocks we like better than Astera Labs
- Williams-Sonoma’s Quarter Gave Bulls More Than Just a Beat-and-Raise
- Alcoa’s Gallium Project Opens a New Door Beyond Aluminum
- Oura’s $16 Billion IPO Could Put a New Price on Wearable Tech
- Can Tesla’s Flying Roadster Distract From Its Real Risks?
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.
